XML 131 R110.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation Share-Based Compensation - Restricted Stock and Performance Shares (Details) - $ / shares
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 45.22 $ 41.06
Ending balance, Weighted Average Grant Date Fair Value $ 49.30 $ 45.22
Restricted Stock [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 102,000  
Granted, Number of Share Units Outstanding 26,000  
Vested, Number of Share Units Outstanding 39,000  
Forfeited, Number of Share Units Outstanding (4,000)  
Ending balance, Number of Share Units Outstanding 85,000 102,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 113.79  
Granted, Weighted Average Grant Date Fair Value 166.19  
Vested, Weighted Average Grant Date Fair Value 103.89  
Forfeited, Weighted Average Grant Date Fair Value 132.13  
Ending balance, Weighted Average Grant Date Fair Value $ 133.17 $ 113.79
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]    
Beginning balance, Number of Share Units Outstanding 89,000  
Granted, Number of Share Units Outstanding 33,000  
Net increase due to estimated performance, Number of Share Units Outstanding 28,000  
Vested, Number of Share Units Outstanding 51,000  
Ending balance, Number of Share Units Outstanding 99,000 89,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]    
Beginning balance, Weighted Average Grant Date Fair Value $ 119.39  
Granted, Weighted Average Grant Date Fair Value 166.19  
Net increase due to estimated performance, Weighted Average Grant Date Fair Value 142.72  
Vested, Weighted Average Grant Date Fair Value 113.28  
Ending balance, Weighted Average Grant Date Fair Value $ 144.65 $ 119.39